Lenient rate control versus strict rate control for atrial fibrillation: a statistical analysis plan for the Danish Atrial Fibrillation (DanAF) randomized clinical trial

[1]  Mukesh Srivastava,et al.  Biostatistics Decoded , 2023, Journal of the Royal Statistical Society Series A: Statistics in Society.

[2]  T. Wang,et al.  CHA2DS2-VASc score stratifies mortality risk in patients with and without atrial fibrillation , 2021, Open Heart.

[3]  J. McMurray,et al.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.

[4]  S. Halpern,et al.  Hospital-free Days: A Pragmatic and Patient-centered Outcome for Trials Among Critically and Seriously Ill Patients. , 2021, American journal of respiratory and critical care medicine.

[5]  A. Brandes,et al.  Lenient rate control versus strict rate control for atrial fibrillation: a protocol for the Danish Atrial Fibrillation (DanAF) randomised clinical trial , 2021, BMJ Open.

[6]  G. Breithardt,et al.  Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. , 2020, The New England journal of medicine.

[7]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[8]  H. Putter,et al.  Assessment of assumptions of statistical analysis methods in randomised clinical trials: the what and how , 2020, BMJ Evidence-Based Medicine.

[9]  Emily C. O'Brien,et al.  Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score. , 2019, Circulation. Cardiovascular quality and outcomes.

[10]  Per Winkel,et al.  Assessing assumptions for statistical analyses in randomised clinical trials , 2019, BMJ Evidence-Based Medicine.

[11]  K. Anstrom,et al.  Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial , 2019, JAMA.

[12]  Per Winkel,et al.  When and how should multiple imputation be used for handling missing data in randomised clinical trials – a practical guide with flowcharts , 2017, BMC Medical Research Methodology.

[13]  Per Winkel,et al.  Count Data Analysis in Randomised Clinical Trials , 2015 .

[14]  J. Jakobsen,et al.  The thresholds for statistical and clinical significance – a five-step procedure for evaluation of intervention effects in randomised clinical trials , 2014, BMC Medical Research Methodology.

[15]  P. Kirchhof,et al.  The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  B. Kahan,et al.  Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis , 2012, BMJ : British Medical Journal.

[17]  B. Kahan,et al.  Improper analysis of trials randomised using stratified blocks or minimisation , 2012, Statistics in medicine.

[18]  H. Crijns,et al.  The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study. , 2011, Journal of the American College of Cardiology.

[19]  Michele Tarsilla.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[20]  D. Packer,et al.  Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect. , 2010, Journal of the American College of Cardiology.

[21]  Otto Kamp,et al.  Lenient versus strict rate control in patients with atrial fibrillation. , 2010, The New England journal of medicine.

[22]  D. Altman,et al.  Reporting of clinical trials: a review of research funders' guidelines , 2008, Trials.

[23]  Yan D. Zhao,et al.  Wilcoxon–Mann–Whitney Test: Stratify or Not? , 2008, Journal of biopharmaceutical statistics.

[24]  Svend Juul,et al.  An Introduction to Stata for Health Researchers , 2006 .

[25]  T. Peters,et al.  Design, analysis and presentation of factorial randomised controlled trials , 2003, BMC medical research methodology.

[26]  Douglas G. Altman,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[27]  S. Connolly,et al.  Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. , 2002, American heart journal.

[28]  Roger Newson,et al.  Parameters behind “Nonparametric” Statistics: Kendall's tau, Somers’ D and Median Differences , 2002 .

[29]  James R. Dixon,et al.  The International Conference on Harmonization Good Clinical Practice guideline. , 1999, Quality assurance.

[30]  E. Lehmann,et al.  Nonparametrics: Statistical Methods Based on Ranks , 1976 .

[31]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..